New drug trial aims to stop deadly clots after knee surgery
NCT ID NCT06180889
Summary
This study is testing whether a new drug called KN060 works better than the standard medication (enoxaparin) at preventing dangerous blood clots in people having total knee replacement surgery. Researchers are comparing different doses of KN060 in 241 patients to see how well it prevents clots and how safe it is. The main goal is to find out if KN060 reduces the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), which are serious complications after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE ARTHROPLASTY, TOTAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Sixth People's Hospital
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.